✦ LIBER ✦

Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503

Book ID: 117659456
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 142 KB
Volume: 38
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)80764-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

519 Preclinical evaluation of the second

519 Preclinical evaluation of the second generation vascular disrupting agent OXI 4503

✍ W. Shi; H.W. Salmon; A.M. Rojiani; D.W. Siemann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Preclinical evaluation of the novel mult

Preclinical evaluation of the novel multi-targeted agent R1530

✍ Kenneth Kolinsky; Christian Tovar; Yu-E Zhang; Aruna Railkar; Hong Yang; Daisy C 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 464 KB

Preclinical pharmacology and antitumour

Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120

✍ M. I. Walton; P. Goddard; L. R. Kelland; D. E. Thurston; K. R. Harrap 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 225 KB

Enhancement of radiation therapy by the

Enhancement of radiation therapy by the novel vascular targeting agent ZD6126

✍ Dietmar W Siemann; Amyn M Rojiani 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Preclinical Study of the Novel Vascular

Preclinical Study of the Novel Vascular Occluding Agent, WST11, for Photodynamic Therapy of the Canine Prostate

✍ Chevalier, Simone; Anidjar, Maurice; Scarlata, Eleonora; Hamel, Lucie; Scherz, A 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 662 KB

Preclinical and Clinical Development of

Preclinical and Clinical Development of Novel Agents That Target the Protein Kinase C Family

✍ Maria Serova; Aïda Ghoul; Karim A. Benhadji; Esteban Cvitkovic; Sandrine Faivre; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 295 KB